$15.97
-0.08-0.50%
At close: -
$15.00
-0.97-6.07%
After Hours: 6:46 PM EDT
Comments
Loading...
Latest Arcturus Therapeutics Stock News | NASDAQ:ARCT | Benzinga
Get the latest news on Arcturus Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Arcturus Therapeutics performance
Categories: All
Thursday, March 06, 2025
Tuesday, February 18, 2025
Friday, February 14, 2025
Friday, January 31, 2025
Tuesday, January 28, 2025
Monday, January 13, 2025
Friday, January 10, 2025
Tuesday, January 07, 2025
Monday, January 06, 2025
Tuesday, December 17, 2024
Monday, December 16, 2024
Thursday, November 14, 2024
Monday, November 11, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Tuesday, October 01, 2024
Monday, September 30, 2024
Friday, September 13, 2024
Monday, September 09, 2024
Tuesday, September 03, 2024
Monday, August 19, 2024
Monday, August 12, 2024
Thursday, August 08, 2024
Tuesday, August 06, 2024
Monday, August 05, 2024
Tuesday, July 02, 2024
Monday, July 01, 2024
Wednesday, June 26, 2024
Thursday, June 13, 2024
Tuesday, June 11, 2024
Friday, June 07, 2024
Tuesday, May 28, 2024
- Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
- Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
- Market-Moving News for May 28th
- Arcutus Therapeutics Holdings shares are trad...
- Arcturus Therapeutics Reports Phase 1b Data f...